Related Experiment Video
Updated: Jan 31, 2026

Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
Effect of ProRoot MTA® and Biodentine® on osteoclastic differentiation and activity of mouse bone marrow macrophages
Miri Kim1, Soojung Kim1, Hyunjung Ko1
1Asan Medical Center, University of Ulsan, Department of Conservative Dentistry, Seoul, Korea.
Objectives:
This investigation aimed to assess the differentiation inhibitory effects of ProRoot MTA® (PMTA) and Biodentine® (BIOD) on osteoclasts originated from murine bone marrow macrophages (BMMs) and compare these effects with those of alendronate (ALD).
Materials And Methods:
Mouse BMMs were cultured to differentiate into osteoclasts with macrophage colony-stimulating factor and receptor activator of NF-κB (RANKL), treated with lipopolysaccharide. After application with PMTA, BIOD, or ALD, cell toxicities were examined using WST-1 assay kit, and RANKL-induced osteoclast differentiation and activities were determined by resorption pit formation assay and tartrate-resistant acid phosphate (TRAP) staining. The mRNA levels of osteoclast activity-related genes were detected with quantitative real time polymerase chain reaction. Expressions of molecular signaling pathways were assessed by western blot. All data were statistically analyzed with one-way ANOVA and Tukey's post-hoc test (p<0.05).
Results:
Mouse BMMs applied with PMTA, BIOD, or ALD showed highly reduced levels of TRAP-positive osteoclasts. The BIOD treated specimens suppressed mRNA expressions of cathepsin K, TRAP, and c-Fos. Nonetheless, it showed a lower effect than PMTA or ALD applications. Compared with ALD, PMTA and BIOD decreased RANKL-mediated phosphorylation of ERK1/2 and IκBα.
Conclusions:
PMTA and BIOD showed the inhibitory effect on osteoclast differentiation and activities similar to that of ALD through IκB phosphorylation and suppression of ERK signaling pathways.
Insights
ProRoot MTA (PMTA) and Biodentine (BIOD) inhibit osteoclast differentiation and activity, similar to alendronate (ALD). These dental materials impact key signaling pathways involved in bone resorption.
Area of Science:
- Biomaterials Science
- Cell Biology
- Dental Materials
Background:
- Osteoclasts are crucial for bone resorption and are implicated in various bone pathologies.
- Understanding the effects of dental materials on osteoclastogenesis is vital for clinical applications.
- Alendronate (ALD) is a known inhibitor of osteoclast activity.
Purpose of the Study:
- To evaluate the osteoclast differentiation inhibitory effects of ProRoot MTA (PMTA) and Biodentine (BIOD).
- To compare the effects of PMTA and BIOD with alendronate (ALD) on osteoclasts.
- To investigate the molecular mechanisms underlying the inhibitory actions of PMTA and BIOD.
Main Methods:
- Murine bone marrow macrophages (BMMs) were differentiated into osteoclasts.
- Cells were treated with PMTA, BIOD, or ALD.
- Osteoclast differentiation, activity (resorption pits, TRAP staining), gene expression (RT-qPCR), and signaling pathways (Western blot) were assessed.
Main Results:
- PMTA, BIOD, and ALD significantly reduced the number of TRAP-positive osteoclasts.
- BIOD showed a lesser inhibitory effect on osteoclast-related gene expression (cathepsin K, TRAP, c-Fos) compared to PMTA and ALD.
- PMTA and BIOD suppressed RANKL-mediated phosphorylation of ERK1/2 and IκBα signaling pathways.
Conclusions:
- ProRoot MTA and Biodentine exhibit inhibitory effects on osteoclast differentiation and activity.
- These effects are comparable to alendronate and are mediated through the inhibition of IκB phosphorylation and ERK signaling.
- PMTA and BIOD represent potential therapeutic agents for conditions involving excessive osteoclast activity.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Bone Structure
Bone Remodeling
Compact Bone
Compact bone, also called cortical bone, is the denser, stronger of the two types of bone tissue. It is found under the periosteum and in the diaphyses of long bones, where it provides support and protection. The microscopic structural unit of compact bone is called an osteon, or haversian system. Each osteon is composed of concentric rings of calcified...

